Dr. Tandra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8111 S Emerson Ave
Ste 105
Indianapolis, IN 46237Phone+1 317-528-5500Fax+1 317-528-6316
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 2004 - 2007
Osmania Medical College NTR UHSClass of 1999
Certifications & Licensure
SD State Medical License Active through 2027
FL State Medical License 2014 - 2026
IN State Medical License 2006 - 2025
OH State Medical License 2009 - 2025
MI State Medical License 2004 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2013
Clinical Trials
- Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia Start of enrollment: 2019 Dec 06
Publications & Presentations
PubMed
- Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review St...Shanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, John Carter, May Chien
Arthritis & Rheumatology. 2025-02-01 - 10 citationsLow dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.Anand Tandra, Fahrettin Covut, Brenda W. Cooper, Richard J. Creger, Lauren Brister
Leukemia & Lymphoma. 2018-07-01 - 25 citationsDonor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for...Lauren E. Caldemeyer, Luke P. Akard, John R. Edwards, Anand Tandra, Dawn R. Wagenknecht
Biology of Blood and Marrow Transplantation. 2017-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
